UTUC Guidelines Panel Two-Part Series
About the Webinar
Jonathan A. Coleman, MD
Memorial Sloan Kettering Cancer Center, New York, New York
Phillip M. Pierorazio, MD
Department of Urology, Penn Medicine, Philadelphia, Pennsylvania
Webinar Part 2: Interactive Discussion with UTUC Guideline Panelists
Live Discussion of the New AUA/SUO Guideline: Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma
Join us for Part 2 of the AUANewsWorthy Webinar series featuring members of the AUA’s Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO 2023 Guideline Panel. Engage directly with the panel experts via Zoom to ask questions about how the guideline applies to your day-to-day practice.
The purpose of the Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline is to provide a useful reference on the effective evidence-based diagnoses and management of non-metastatic upper tract urothelial carcinoma (UTUC). Drs. Coleman, Pierorazio, and Psutka all served as Panel Members for the Guideline. The UTUC Panel was created in 2021 by the American Urological Association Education and Research, Inc. (AUAER) to develop a clinical guideline addressing the management of localized or regionally advanced UTUC. This guideline was developed in collaboration with the Society of Urologic Oncology (SUO).
The Journal of Urology® article: Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline
AUA2023 Abstract: Is There a Racial Disparity in the Outcomes of Patients with Non-Metastatic Upper Tract Urothelial Urothelial Carcinoma Who are Treated Surgically? A North American Nationwide Analysis